Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Renal Anemia Market to Reach USD 3.92 Billion by 2032

Global Renal Anemia Market Size Study, by Anemia Type (Iron Deficiency Anemia, Vitamin B12 Deficiency Anemia, Folate Deficiency Anemia, Aplastic Anemia, Hemolytic Anemia, Sickle Cell Anemia), by Treatment Type (Erythropoiesis-Stimulating Agents (ESAs), Iron Supplementation, Vitamin B12 Supplementation, Folate Supplementation, Transfusion Therapy, Bone Marrow Transplant), by Disease Severity (Mild, Moderate, Severe), by End-User (Hospitals, Dialysis Centers, Clinics, Home Healthcare), by Route of Administration (Intravenous, Subcutaneous, Oral) and Regional Forecasts 2024-2032

Product Code: HLSDT-18810051
Publish Date: 25-08-2024
Page: 200

The Global Renal Anemia Market was valued at approximately USD 2.31 Billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 6.05% over the forecast period from 2024 to 2032. Renal anemia is a condition characterized by a decrease in red blood cells due to chronic kidney disease (CKD). The kidneys, which normally produce erythropoietin, a hormone crucial for red blood cell production, become impaired and fail to produce enough of this hormone. As a result, patients experience symptoms such as fatigue, weakness, and pallor. Effective management often includes erythropoiesis-stimulating agents (ESAs), iron supplements, and addressing the underlying kidney condition to improve red blood cell levels and overall health. The market is experiencing transformative shifts, primarily driven by technological advancements in diagnostics and the development of new erythropoiesis-stimulating agents (ESAs). The increasing prevalence of chronic kidney disease (CKD), coupled with growing awareness and early detection initiatives, is fueling the demand for renal anemia treatments.
The Key market drivers include the escalating burden of CKD, advancements in early detection and diagnosis, and the emergence of innovative therapies. There are significant opportunities for the development of non-ESA-based therapies, targeted drug delivery systems, and personalized treatment regimens. Additionally, the market is witnessing the emergence of biosimilars, offering cost-effective treatment options and expanding access to therapy. Regulatory approvals for novel therapies and the expansion of reimbursement policies are expected to further drive market growth. A major risk factor for developing renal anemia is chronic kidney disease. With the increase in CKD prevalence globally, the need for effective treatment options for renal anemia is expected to surge. According to the National Kidney Foundation, approximately 37 million adults in the United States have CKD, and this figure is expected to rise to 47 million by 2030. This rising incidence of CKD is a key driver of growth in the Global Renal Anemia Market.
The key region in the Global Renal Anemia Market includes North America, Europe, Asia-Pacific, South America, and the Middle East & Africa. In 2023, North America is expected to hold the largest market share, due to its advanced healthcare infrastructure, high prevalence of chronic kidney disease, and strong emphasis on innovative treatments. The region benefits from robust research and development capabilities, leading to the introduction of advanced therapies and technologies for managing renal anemia. Additionally, a high rate of early diagnosis and a well-established market for pharmaceuticals and healthcare services contribute to North America’s significant market share. The Asia-Pacific region is anticipated to be the fastest-growing market during the forecast period 2024-2032. The growth in APAC is attributed to the increasing prevalence of chronic kidney disease and the rising demand for dialysis treatments in the region.

Major market players included in this report are:
Roche
AstraZeneca PLC
Fresenius Medical Care AG & Co. KGAA
Johnson & Johnson
Astellas Pharma Inc.
Amgen Inc.
Otsuka Pharmaceutical Co., Ltd.
Merck & Co., Inc.
Teva Pharmaceutical Industries Ltd.
Novartis AG
AbbVie Inc.
Sanofi
Pfizer Inc.
Baxter International Inc.
DaVita Inc.

The detailed segments and sub-segments of the market are explained below:
By Anemia Type:
Iron Deficiency Anemia
Vitamin B12 Deficiency Anemia
Folate Deficiency Anemia
Aplastic Anemia
Hemolytic Anemia
Sickle Cell Anemia

By Treatment Type:
Erythropoiesis-Stimulating Agents (ESAs)
Iron Supplementation
Vitamin B12 Supplementation
Folate Supplementation
Transfusion Therapy
Bone Marrow Transplant

By Disease Severity:
Mild
Moderate
Severe

By End-User:
Hospitals
Dialysis Centers
Clinics
Home Healthcare

By Route of Administration:
Intravenous
Subcutaneous
Oral

By Region:
North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico
Rest of Latin America

Middle East & Africa
Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Renal Anemia Market Executive Summary
1.1. Global Renal Anemia Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Anemia Type
1.3.2. By Treatment Type
1.3.3. By Disease Severity
1.3.4. By End-User
1.3.5. By Route of Administration
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Renal Anemia Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Renal Anemia Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Prevalence of Chronic Kidney Disease (CKD)
3.1.2. Growing Adoption of Erythropoiesis-Stimulating Agents (ESAs)
3.1.3. Rising Demand for Non-Invasive Treatment Options
3.2. Market Challenges
3.2.1. High Cost of Treatment
3.2.2. Side Effects Associated with ESAs
3.3. Market Opportunities
3.3.1. Development of Non-ESA-Based Therapies
3.3.2. Targeted Drug Delivery Systems
3.3.3. Personalized Treatment Regimens

Chapter 4. Global Renal Anemia Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Renal Anemia Market Size & Forecasts by Anemia Type 2022-2032
5.1. Segment Dashboard
5.2. Global Renal Anemia Market: Anemia Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Iron Deficiency Anemia
5.2.2. Vitamin B12 Deficiency Anemia
5.2.3. Folate Deficiency Anemia
5.2.4. Aplastic Anemia
5.2.5. Hemolytic Anemia
5.2.6. Sickle Cell Anemia

Chapter 6. Global Renal Anemia Market Size & Forecasts by Treatment Type 2022-2032
6.1. Segment Dashboard
6.2. Global Renal Anemia Market: Treatment Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Erythropoiesis-Stimulating Agents (ESAs)
6.2.2. Iron Supplementation
6.2.3. Vitamin B12 Supplementation
6.2.4. Folate Supplementation
6.2.5. Transfusion Therapy
6.2.6. Bone Marrow Transplant

Chapter 7. Global Renal Anemia Market Size & Forecasts by Disease Severity 2022-2032
7.1. Segment Dashboard
7.2. Global Renal Anemia Market: Disease Severity Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Mild
7.2.2. Moderate
7.2.3. Severe

Chapter 8. Global Renal Anemia Market Size & Forecasts by End-User 2022-2032
8.1. Segment Dashboard
8.2. Global Renal Anemia Market: End-User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Hospitals
8.2.2. Dialysis Centers
8.2.3. Clinics
8.2.4. Home Healthcare

Chapter 9. Global Renal Anemia Market Size & Forecasts by Route of Administration 2022-2032
9.1. Segment Dashboard
9.2. Global Renal Anemia Market: Route of Administration Revenue Trend Analysis, 2022 & 2032 (USD Billion)
9.2.1. Intravenous
9.2.2. Subcutaneous
9.2.3. Oral

Chapter 10. Global Renal Anemia Market Size & Forecasts by Region 2022-2032
10.1. North America Renal Anemia Market
10.1.1. U.S. Renal Anemia Market
10.1.1.1. Anemia Type breakdown size & forecasts, 2022-2032
10.1.1.2. Treatment Type breakdown size & forecasts, 2022-2032
10.1.1.3. Disease Severity breakdown size & forecasts, 2022-2032
10.1.1.4. End-User breakdown size & forecasts, 2022-2032
10.1.1.5. Route of Administration breakdown size & forecasts, 2022-2032
10.1.2. Canada Renal Anemia Market
10.2. Europe Renal Anemia Market
10.2.1. U.K. Renal Anemia Market
10.2.2. Germany Renal Anemia Market
10.2.3. France Renal Anemia Market
10.2.4. Spain Renal Anemia Market
10.2.5. Italy Renal Anemia Market
10.2.6. Rest of Europe Renal Anemia Market
10.3. Asia-Pacific Renal Anemia Market
10.3.1. China Renal Anemia Market
10.3.2. India Renal Anemia Market
10.3.3. Japan Renal Anemia Market
10.3.4. Australia Renal Anemia Market
10.3.5. South Korea Renal Anemia Market
10.3.6. Rest of Asia Pacific Renal Anemia Market
10.4. Latin America Renal Anemia Market
10.4.1. Brazil Renal Anemia Market
10.4.2. Mexico Renal Anemia Market
10.4.3. Rest of Latin America Renal Anemia Market
10.5. Middle East & Africa Renal Anemia Market
10.5.1. Saudi Arabia Renal Anemia Market
10.5.2. South Africa Renal Anemia Market
10.5.3. Rest of Middle East & Africa Renal Anemia Market

Chapter 11. Competitive Intelligence
11.1. Key Company SWOT Analysis
11.1.1. Company 1
11.1.2. Company 2
11.1.3. Company 3
11.2. Top Market Strategies
11.3. Company Profiles
11.3.1. Roche
11.3.1.1. Key Information
11.3.1.2. Overview
11.3.1.3. Financial (Subject to Data Availability)
11.3.1.4. Product Summary
11.3.1.5. Market Strategies
11.3.2. AstraZeneca PLC
11.3.3. Fresenius Medical Care AG & Co. KGAA
11.3.4. Johnson & Johnson
11.3.5. Astellas Pharma Inc.
11.3.6. Amgen Inc.
11.3.7. Otsuka Pharmaceutical Co., Ltd.
11.3.8. Merck & Co., Inc.
11.3.9. Teva Pharmaceutical Industries Ltd.
11.3.10. Novartis AG
11.3.11. AbbVie Inc.
11.3.12. Sanofi
11.3.13. Pfizer Inc.
11.3.14. Baxter International Inc.
11.3.15. DaVita Inc.

Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now